Skip to main content
Top
Published in: Inflammation 2/2013

01-04-2013

Association Study of IFIH1 rs1990760 Polymorphism with Systemic Lupus Erythematosus in a Chinese Population

Authors: Han Cen, Rui-Xue Leng, Wei Wang, Mo Zhou, Chen-Chen Feng, Yan Zhu, Xiao-Ke Yang, Mei Yang, Yu Zhai, Bao-Zhu Li, Juan Liu, Hai-Feng Pan, Dong-Qing Ye

Published in: Inflammation | Issue 2/2013

Login to get access

Abstract

Systemic lupus erythematosus (SLE) is a complex autoimmune disease arising from the action of multiple genetic and environmental risk factors. The aim of this study was to examine the association of a single-nucleotide polymorphism, rs1990760, of the interferon induced with helicase C domain 1 (IFIH1) gene with SLE in a Chinese population. A total of 877 SLE patients and 978 healthy control subjects were enrolled in the present study. The genotype of the IFIH1 rs1990760 polymorphism was determined by Sequenom MassARRAY technology. The IFIH1 rs1990760 T allele was significantly increased in patient group compared with control subjects (T versus C, Odds ratio = 1.20, 95 % confidence interval = 1.02–1.40). However, no significant difference in genotype distribution was found between cases and controls (P = 0.07). No significant evidence was detected for the association of the IFIH1 rs1990760 polymorphism with SLE under neither dominant nor recessive model (TT + TC versus CC, P = 0.06; TT versus TC + CC, P = 0.08). We also analyzed the association of the IFIH1 rs1990760 T allele with clinical features, whereas no significant signal was found. In conclusion, our study represents the first report demonstrating an association of the IFIH1 rs1990760 polymorphism with SLE susceptibility in a Chinese population.
Literature
1.
go back to reference Münz, C., J.D. Lünemann, M.T. Getts, and S.D. Miller. 2009. Antiviral immune responses: triggers of or triggered by autoimmunity? Nature Reviews Immunology 9: 246–258.PubMedCrossRef Münz, C., J.D. Lünemann, M.T. Getts, and S.D. Miller. 2009. Antiviral immune responses: triggers of or triggered by autoimmunity? Nature Reviews Immunology 9: 246–258.PubMedCrossRef
2.
go back to reference Takeuchi, O., and S. Akira. 2010. Pattern recognition receptors and inflammation. Cell 140: 805–820.PubMedCrossRef Takeuchi, O., and S. Akira. 2010. Pattern recognition receptors and inflammation. Cell 140: 805–820.PubMedCrossRef
3.
go back to reference Stetson, D.B., and R. Medzhitov. 2006. Antiviral defense: interferons and beyond. The Journal of Experimental Medicine 203: 1837–1841.PubMedCrossRef Stetson, D.B., and R. Medzhitov. 2006. Antiviral defense: interferons and beyond. The Journal of Experimental Medicine 203: 1837–1841.PubMedCrossRef
4.
go back to reference Chistiakov, D.A. 2010. Interferon induced with helicase C domain 1 (IFIH1) and virus-induced autoimmunity: a review. Viral Immunology 23: 3–15.PubMedCrossRef Chistiakov, D.A. 2010. Interferon induced with helicase C domain 1 (IFIH1) and virus-induced autoimmunity: a review. Viral Immunology 23: 3–15.PubMedCrossRef
5.
go back to reference Yoneyama, M., M. Kikuchi, K. Matsumoto, T. Imaizumi, M. Miyagishi, K. Taira, E. Foy, Y.M. Loo, M. Gale Jr., S. Akira, S. Yonehara, A. Kato, and T. Fujita. 2005. Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. Journal of Immunology 175: 2851–2858. Yoneyama, M., M. Kikuchi, K. Matsumoto, T. Imaizumi, M. Miyagishi, K. Taira, E. Foy, Y.M. Loo, M. Gale Jr., S. Akira, S. Yonehara, A. Kato, and T. Fujita. 2005. Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. Journal of Immunology 175: 2851–2858.
6.
go back to reference Smyth, D.J., J.D. Cooper, R. Bailey, S. Field, O. Burren, L.J. Smink, C. Guja, C. Ionescu-Tirgoviste, B. Widmer, D.B. Dunger, D.A. Savage, N.M. Walker, D.G. Clayton, and J.A. Todd. 2006. A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region. Nature Genetics 38: 617–619.PubMedCrossRef Smyth, D.J., J.D. Cooper, R. Bailey, S. Field, O. Burren, L.J. Smink, C. Guja, C. Ionescu-Tirgoviste, B. Widmer, D.B. Dunger, D.A. Savage, N.M. Walker, D.G. Clayton, and J.A. Todd. 2006. A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region. Nature Genetics 38: 617–619.PubMedCrossRef
7.
go back to reference Gregersen, P.K., and L.M. Olsson. 2009. Recent advances in the genetics of autoimmune disease. Annual Review of Immunology 27: 363–391.PubMedCrossRef Gregersen, P.K., and L.M. Olsson. 2009. Recent advances in the genetics of autoimmune disease. Annual Review of Immunology 27: 363–391.PubMedCrossRef
8.
go back to reference International Consortium for Systemic Lupus Erythematosus Genetics (SLEGEN), J.B. Harley, M.E. Alarcón-Riquelme, L.A. Criswell, C.O. Jacob, R.P. Kimberly, K.L. Moser, B.P. Tsao, T.J. Vyse, C.D. Langefeld, S.K. Nath, J.M. Guthridge, B.L. Cobb, D.B. Mirel, M.C. Marion, A.H. Williams, J. Divers, W. Wang, S.G. Frank, B. Namjou, S.B. Gabriel, A.T. Lee, P.K. Gregersen, T.W. Behrens, K.E. Taylor, M. Fernando, R. Zidovetzki, P.M. Gaffney, J.C. Edberg, J.D. Rioux, J.O. Ojwang, J.A. James, J.T. Merrill, G.S. Gilkeson, M.F. Seldin, H. Yin, E.C. Baechler, Q.Z. Li, E.K. Wakeland, G.R. Bruner, K.M. Kaufman, and J.A. Kelly. 2008. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nature Genetics 40: 204–210.PubMedCrossRef International Consortium for Systemic Lupus Erythematosus Genetics (SLEGEN), J.B. Harley, M.E. Alarcón-Riquelme, L.A. Criswell, C.O. Jacob, R.P. Kimberly, K.L. Moser, B.P. Tsao, T.J. Vyse, C.D. Langefeld, S.K. Nath, J.M. Guthridge, B.L. Cobb, D.B. Mirel, M.C. Marion, A.H. Williams, J. Divers, W. Wang, S.G. Frank, B. Namjou, S.B. Gabriel, A.T. Lee, P.K. Gregersen, T.W. Behrens, K.E. Taylor, M. Fernando, R. Zidovetzki, P.M. Gaffney, J.C. Edberg, J.D. Rioux, J.O. Ojwang, J.A. James, J.T. Merrill, G.S. Gilkeson, M.F. Seldin, H. Yin, E.C. Baechler, Q.Z. Li, E.K. Wakeland, G.R. Bruner, K.M. Kaufman, and J.A. Kelly. 2008. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nature Genetics 40: 204–210.PubMedCrossRef
9.
go back to reference Gateva, V., J.K. Sandling, G. Hom, K.E. Taylor, S.A. Chung, X. Sun, W. Ortmann, R. Kosoy, R.C. Ferreira, G. Nordmark, I. Gunnarsson, E. Svenungsson, L. Padyukov, G. Sturfelt, A. Jönsen, A.A. Bengtsson, S. Rantapää-Dahlqvist, E.C. Baechler, E.E. Brown, G.S. Alarcón, J.C. Edberg, R. Ramsey-Goldman, G. McGwin Jr., J.D. Reveille, L.M. Vilá, R.P. Kimberly, S. Manzi, M.A. Petri, A. Lee, P.K. Gregersen, M.F. Seldin, L. Rönnblom, L.A. Criswell, A.C. Syvänen, T.W. Behrens, and R.R. Graham. 2009. A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nature Genetics 41: 1228–1233.PubMedCrossRef Gateva, V., J.K. Sandling, G. Hom, K.E. Taylor, S.A. Chung, X. Sun, W. Ortmann, R. Kosoy, R.C. Ferreira, G. Nordmark, I. Gunnarsson, E. Svenungsson, L. Padyukov, G. Sturfelt, A. Jönsen, A.A. Bengtsson, S. Rantapää-Dahlqvist, E.C. Baechler, E.E. Brown, G.S. Alarcón, J.C. Edberg, R. Ramsey-Goldman, G. McGwin Jr., J.D. Reveille, L.M. Vilá, R.P. Kimberly, S. Manzi, M.A. Petri, A. Lee, P.K. Gregersen, M.F. Seldin, L. Rönnblom, L.A. Criswell, A.C. Syvänen, T.W. Behrens, and R.R. Graham. 2009. A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nature Genetics 41: 1228–1233.PubMedCrossRef
10.
go back to reference Cunninghame Graham, D.S., D.L. Morris, T.R. Bhangale, L.A. Criswell, A.C. Syvänen, L. Rönnblom, T.W. Behrens, R.R. Graham, and T.J. Vyse. 2011. Association of NCF2, IKZF1, IRF8, IFIH1, and TYK2 with systemic lupus erythematosus. PLoS Genetics 7: e1002341.PubMedCrossRef Cunninghame Graham, D.S., D.L. Morris, T.R. Bhangale, L.A. Criswell, A.C. Syvänen, L. Rönnblom, T.W. Behrens, R.R. Graham, and T.J. Vyse. 2011. Association of NCF2, IKZF1, IRF8, IFIH1, and TYK2 with systemic lupus erythematosus. PLoS Genetics 7: e1002341.PubMedCrossRef
11.
go back to reference Gono, T., Y. Kawaguchi, T. Sugiura, T. Furuya, M. Kawamoto, M. Hanaoka, and H. Yamanaka. 2010. Interferon-induced helicase (IFIH1) polymorphism with systemic lupus erythematosus and dermatomyositis/polymyositis. Modern Rheumatology 20: 466–470.PubMedCrossRef Gono, T., Y. Kawaguchi, T. Sugiura, T. Furuya, M. Kawamoto, M. Hanaoka, and H. Yamanaka. 2010. Interferon-induced helicase (IFIH1) polymorphism with systemic lupus erythematosus and dermatomyositis/polymyositis. Modern Rheumatology 20: 466–470.PubMedCrossRef
12.
go back to reference Hochberg, M.C. 1997. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis and Rheumatism 40: 1725.PubMedCrossRef Hochberg, M.C. 1997. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis and Rheumatism 40: 1725.PubMedCrossRef
13.
go back to reference Kang, D.C., R.V. Gopalkrishnan, Q. Wu, E. Jankowsky, A.M. Pyle, and P.B. Fisher. 2002. mda-5: an interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties. Proceedings of the National Academy of Sciences of the United States of America 99: 637–642.PubMedCrossRef Kang, D.C., R.V. Gopalkrishnan, Q. Wu, E. Jankowsky, A.M. Pyle, and P.B. Fisher. 2002. mda-5: an interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties. Proceedings of the National Academy of Sciences of the United States of America 99: 637–642.PubMedCrossRef
14.
go back to reference Meylan, E., J. Tschopp, and M. Karin. 2006. Intracellular pattern recognition receptors in the host response. Nature 442: 39–44.PubMedCrossRef Meylan, E., J. Tschopp, and M. Karin. 2006. Intracellular pattern recognition receptors in the host response. Nature 442: 39–44.PubMedCrossRef
15.
go back to reference Kato, H., O. Takeuchi, S. Sato, M. Yoneyama, M. Yamamoto, K. Matsui, S. Uematsu, A. Jung, T. Kawai, K.J. Ishii, O. Yamaguchi, K. Otsu, T. Tsujimura, C.S. Koh, C. Reis e Sousa, Y. Matsuura, T. Fujita, and S. Akira. 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441: 101–105.PubMedCrossRef Kato, H., O. Takeuchi, S. Sato, M. Yoneyama, M. Yamamoto, K. Matsui, S. Uematsu, A. Jung, T. Kawai, K.J. Ishii, O. Yamaguchi, K. Otsu, T. Tsujimura, C.S. Koh, C. Reis e Sousa, Y. Matsuura, T. Fujita, and S. Akira. 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441: 101–105.PubMedCrossRef
16.
go back to reference Baechler, E.C., F.M. Batliwalla, G. Karypis, P.M. Gaffney, W.A. Ortmann, K.J. Espe, K.B. Shark, W.J. Grande, K.M. Hughes, V. Kapur, P.K. Gregersen, and T.W. Behrens. 2003. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proceedings of the National Academy of Sciences of the United States of America 100: 2610–2615.PubMedCrossRef Baechler, E.C., F.M. Batliwalla, G. Karypis, P.M. Gaffney, W.A. Ortmann, K.J. Espe, K.B. Shark, W.J. Grande, K.M. Hughes, V. Kapur, P.K. Gregersen, and T.W. Behrens. 2003. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proceedings of the National Academy of Sciences of the United States of America 100: 2610–2615.PubMedCrossRef
17.
go back to reference Bennett, L., A.K. Palucka, E. Arce, V. Cantrell, J. Borvak, J. Banchereau, and V. Pascual. 2003. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. The Journal of Experimental Medicine 197: 711–723.PubMedCrossRef Bennett, L., A.K. Palucka, E. Arce, V. Cantrell, J. Borvak, J. Banchereau, and V. Pascual. 2003. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. The Journal of Experimental Medicine 197: 711–723.PubMedCrossRef
18.
go back to reference Santiago-Raber, M.L., R. Baccala, K.M. Haraldsson, D. Choubey, T.A. Stewart, D.H. Kono, and A.N. Theofilopoulos. 2003. Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice. The Journal of Experimental Medicine 197: 777–788.PubMedCrossRef Santiago-Raber, M.L., R. Baccala, K.M. Haraldsson, D. Choubey, T.A. Stewart, D.H. Kono, and A.N. Theofilopoulos. 2003. Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice. The Journal of Experimental Medicine 197: 777–788.PubMedCrossRef
19.
go back to reference Nacionales, D.C., K.M. Kelly-Scumpia, P.Y. Lee, J.S. Weinstein, R. Lyons, E. Sobel, M. Satoh, and W.H. Reeves. 2007. Deficiency of the type I interferon receptor protects mice from experimental lupus. Arthritis and Rheumatism 56: 3770–3783.PubMedCrossRef Nacionales, D.C., K.M. Kelly-Scumpia, P.Y. Lee, J.S. Weinstein, R. Lyons, E. Sobel, M. Satoh, and W.H. Reeves. 2007. Deficiency of the type I interferon receptor protects mice from experimental lupus. Arthritis and Rheumatism 56: 3770–3783.PubMedCrossRef
20.
go back to reference Richez, C., K. Yasuda, R.G. Bonegio, A.A. Watkins, T. Aprahamian, P. Busto, R.J. Richards, C.L. Liu, R. Cheung, P.J. Utz, A. Marshak-Rothstein, and I.R. Rifkin. 2010. IFN regulatory factor 5 is required for disease development in the FcgammaRIIB−/−Yaa and FcgammaRIIB−/− mouse models of systemic lupus erythematosus. Journal of Immunology 184: 796–806.CrossRef Richez, C., K. Yasuda, R.G. Bonegio, A.A. Watkins, T. Aprahamian, P. Busto, R.J. Richards, C.L. Liu, R. Cheung, P.J. Utz, A. Marshak-Rothstein, and I.R. Rifkin. 2010. IFN regulatory factor 5 is required for disease development in the FcgammaRIIB−/−Yaa and FcgammaRIIB−/− mouse models of systemic lupus erythematosus. Journal of Immunology 184: 796–806.CrossRef
21.
go back to reference Crampton, S.P., J.A. Deane, L. Feigenbaum, and S. Bolland. 2012. Ifih1 gene dose effect reveals MDA5-mediated chronic type I IFN gene signature, viral resistance, and accelerated autoimmunity. Journal of Immunology 188: 1451–1459.CrossRef Crampton, S.P., J.A. Deane, L. Feigenbaum, and S. Bolland. 2012. Ifih1 gene dose effect reveals MDA5-mediated chronic type I IFN gene signature, viral resistance, and accelerated autoimmunity. Journal of Immunology 188: 1451–1459.CrossRef
22.
go back to reference Liu, S., H. Wang, Y. Jin, R. Podolsky, M.V. Reddy, J. Pedersen, B. Bode, J. Reed, D. Steed, S. Anderson, P. Yang, A. Muir, L. Steed, D. Hopkins, Y. Huang, S. Purohit, C.Y. Wang, A.K. Steck, A. Montemari, G. Eisenbarth, M. Rewers, and J.X. She. 2009. IFIH1 polymorphisms are significantly associated with type 1 diabetes and IFIH1 gene expression in peripheral blood mononuclear cells. Human Molecular Genetics 18: 358–365.PubMedCrossRef Liu, S., H. Wang, Y. Jin, R. Podolsky, M.V. Reddy, J. Pedersen, B. Bode, J. Reed, D. Steed, S. Anderson, P. Yang, A. Muir, L. Steed, D. Hopkins, Y. Huang, S. Purohit, C.Y. Wang, A.K. Steck, A. Montemari, G. Eisenbarth, M. Rewers, and J.X. She. 2009. IFIH1 polymorphisms are significantly associated with type 1 diabetes and IFIH1 gene expression in peripheral blood mononuclear cells. Human Molecular Genetics 18: 358–365.PubMedCrossRef
23.
go back to reference Zouk, H., L. Marchand, and C. Polychronakos. 2010. Study of transcriptional effects in Cis at the IFIH1 locus. PLoS One 5: e11564.PubMedCrossRef Zouk, H., L. Marchand, and C. Polychronakos. 2010. Study of transcriptional effects in Cis at the IFIH1 locus. PLoS One 5: e11564.PubMedCrossRef
24.
go back to reference Marinou, I., D.S. Montgomery, M.C. Dickson, M.H. Binks, D.J. Moore, D.E. Bax, and A.G. Wilson. 2007. The interferon induced with helicase domain 1 A946T polymorphism is not associated with rheumatoid arthritis. Arthritis Research & Therapy 9: R40.CrossRef Marinou, I., D.S. Montgomery, M.C. Dickson, M.H. Binks, D.J. Moore, D.E. Bax, and A.G. Wilson. 2007. The interferon induced with helicase domain 1 A946T polymorphism is not associated with rheumatoid arthritis. Arthritis Research & Therapy 9: R40.CrossRef
25.
go back to reference Robinson, T., S.N. Kariuki, B.S. Franek, M. Kumabe, A.A. Kumar, M. Badaracco, R.A. Mikolaitis, G. Guerrero, T.O. Utset, B.E. Drevlow, L.S. Zaacks, J.S. Grober, L.M. Cohen, K.A. Kirou, M.K. Crow, M. Jolly, and T.B. Niewold. 2011. Autoimmune disease risk variant of IFIH1 is associated with increased sensitivity to IFN-α and serologic autoimmunity in lupus patients. Journal of Immunology 187: 1298–1303.CrossRef Robinson, T., S.N. Kariuki, B.S. Franek, M. Kumabe, A.A. Kumar, M. Badaracco, R.A. Mikolaitis, G. Guerrero, T.O. Utset, B.E. Drevlow, L.S. Zaacks, J.S. Grober, L.M. Cohen, K.A. Kirou, M.K. Crow, M. Jolly, and T.B. Niewold. 2011. Autoimmune disease risk variant of IFIH1 is associated with increased sensitivity to IFN-α and serologic autoimmunity in lupus patients. Journal of Immunology 187: 1298–1303.CrossRef
26.
go back to reference Rönnblom, L., G.V. Alm, and M.L. Eloranta. 2011. The type I interferon system in the development of lupus. Seminars in Immunology 23: 113–121.PubMedCrossRef Rönnblom, L., G.V. Alm, and M.L. Eloranta. 2011. The type I interferon system in the development of lupus. Seminars in Immunology 23: 113–121.PubMedCrossRef
27.
go back to reference Han, J.W., H.F. Zheng, Y. Cui, L.D. Sun, D.Q. Ye, Z. Hu, J.H. Xu, Z.M. Cai, W. Huang, G.P. Zhao, H.F. Xie, H. Fang, Q.J. Lu, J.H. Xu, X.P. Li, Y.F. Pan, D.Q. Deng, F.Q. Zeng, Z.Z. Ye, X.Y. Zhang, Q.W. Wang, F. Hao, L. Ma, X.B. Zuo, F.S. Zhou, W.H. Du, Y.L. Cheng, J.Q. Yang, S.K. Shen, J. Li, Y.J. Sheng, X.X. Zuo, W.F. Zhu, F. Gao, P.L. Zhang, Q. Guo, B. Li, M. Gao, F.L. Xiao, C. Quan, C. Zhang, Z. Zhang, K.J. Zhu, Y. Li, D.Y. Hu, W.S. Lu, J.L. Huang, S.X. Liu, H. Li, Y.Q. Ren, Z.X. Wang, C.J. Yang, P.G. Wang, W.M. Zhou, Y.M. Lv, A.P. Zhang, S.Q. Zhang, D. Lin, Y. Li, H.Q. Low, M. Shen, Z.F. Zhai, Y. Wang, F.Y. Zhang, S. Yang, J.J. Liu, and X.J. Zhang. 2009. Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nature Genetics 41: 1234–1237.PubMedCrossRef Han, J.W., H.F. Zheng, Y. Cui, L.D. Sun, D.Q. Ye, Z. Hu, J.H. Xu, Z.M. Cai, W. Huang, G.P. Zhao, H.F. Xie, H. Fang, Q.J. Lu, J.H. Xu, X.P. Li, Y.F. Pan, D.Q. Deng, F.Q. Zeng, Z.Z. Ye, X.Y. Zhang, Q.W. Wang, F. Hao, L. Ma, X.B. Zuo, F.S. Zhou, W.H. Du, Y.L. Cheng, J.Q. Yang, S.K. Shen, J. Li, Y.J. Sheng, X.X. Zuo, W.F. Zhu, F. Gao, P.L. Zhang, Q. Guo, B. Li, M. Gao, F.L. Xiao, C. Quan, C. Zhang, Z. Zhang, K.J. Zhu, Y. Li, D.Y. Hu, W.S. Lu, J.L. Huang, S.X. Liu, H. Li, Y.Q. Ren, Z.X. Wang, C.J. Yang, P.G. Wang, W.M. Zhou, Y.M. Lv, A.P. Zhang, S.Q. Zhang, D. Lin, Y. Li, H.Q. Low, M. Shen, Z.F. Zhai, Y. Wang, F.Y. Zhang, S. Yang, J.J. Liu, and X.J. Zhang. 2009. Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nature Genetics 41: 1234–1237.PubMedCrossRef
28.
go back to reference Yang, W., N. Shen, D.Q. Ye, Q. Liu, Y. Zhang, X.X. Qian, N. Hirankarn, D. Ying, H.F. Pan, C.C. Mok, T.M. Chan, R.W. Wong, K.W. Lee, M.Y. Mok, S.N. Wong, A.M. Leung, X.P. Li, Y. Avihingsanon, C.M. Wong, T.L. Lee, M.H. Ho, P.P. Lee, Y.K. Chang, P.H. Li, R.J. Li, L. Zhang, W.H. Wong, I.O. Ng, C.S. Lau, P.C. Sham, Y.L. Lau, and Asian Lupus Genetics Consortium. 2010. Genome-wide association study in Asian populations identifies variants in ETS1 and WDFY4 associated with systemic lupus erythematosus. PLoS Genetics 6: e1000841.PubMedCrossRef Yang, W., N. Shen, D.Q. Ye, Q. Liu, Y. Zhang, X.X. Qian, N. Hirankarn, D. Ying, H.F. Pan, C.C. Mok, T.M. Chan, R.W. Wong, K.W. Lee, M.Y. Mok, S.N. Wong, A.M. Leung, X.P. Li, Y. Avihingsanon, C.M. Wong, T.L. Lee, M.H. Ho, P.P. Lee, Y.K. Chang, P.H. Li, R.J. Li, L. Zhang, W.H. Wong, I.O. Ng, C.S. Lau, P.C. Sham, Y.L. Lau, and Asian Lupus Genetics Consortium. 2010. Genome-wide association study in Asian populations identifies variants in ETS1 and WDFY4 associated with systemic lupus erythematosus. PLoS Genetics 6: e1000841.PubMedCrossRef
Metadata
Title
Association Study of IFIH1 rs1990760 Polymorphism with Systemic Lupus Erythematosus in a Chinese Population
Authors
Han Cen
Rui-Xue Leng
Wei Wang
Mo Zhou
Chen-Chen Feng
Yan Zhu
Xiao-Ke Yang
Mei Yang
Yu Zhai
Bao-Zhu Li
Juan Liu
Hai-Feng Pan
Dong-Qing Ye
Publication date
01-04-2013
Publisher
Springer US
Published in
Inflammation / Issue 2/2013
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-012-9564-0

Other articles of this Issue 2/2013

Inflammation 2/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.